AP2X-1 is a nuclear ApiAP2-family transcriptional repressor in Toxoplasma gondii that suppresses stage differentiation and sexual commitment to maintain the proliferative tachyzoite program (PMID:40823841). Expressed in tachyzoites and bradyzoites but downregulated in mature merozoites, AP2X-1 is required for efficient tachyzoite invasion and replication, and its loss increases bradyzoite differentiation (PMID:40823841). It acts through physical association with the HDAC3/MORC repressor complex, and genome-wide binding overlaps HDAC3/MORC occupancy at promoters of bradyzoite- and sexual stage-specific genes, where AP2X-1 promotes chromatin compaction and restricts accessibility (PMID:40823841). Consequent to this repression, knockout parasites derepress bradyzoite- and sexual-stage gene programs and give rise to a mixed population of tachyzoite-, bradyzoite-, merozoite-, and sporozoite-like cells, identifying AP2X-1 as a critical negative regulator of stage transitions (PMID:40823841). In vivo, loss of AP2X-1 attenuates virulence and reduces brain cyst formation, linking its repressive function to pathogenesis (PMID:40823841).